Compare
Harrow, Inc. vs Vireo Growth Inc. vs Schrodinger, Inc. vs Evolus, Inc.
| Latest fiscal year | Harrow, Inc. HROW | Vireo Growth Inc. VREOF | Schrodinger, Inc. SDGR | Evolus, Inc. EOLS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $272.30M | $268.77M | $255.87M | $297.18M |
| Revenue growth (YoY) | +36.4% | +170.4% | +23.3% | +11.6% |
| Gross margin | 75.1% | 47.3% | 55.7% | 66.3% |
| Operating margin | 11.2% | -0.4% | -65.2% | -11.0% |
| Net margin | -1.9% | -25.3% | -40.4% | -17.4% |
| Net income | -$5.14M | -$68.11M | -$103.27M | -$51.64M |
| EPS (Diluted) | -$0.14 | -$0.09 | -$1.41 | -$0.80 |
| Operating cash flow | $43.86M | $3.71M | $13.90M | -$42.27M |
| Free cash flow | $42.98M | -$24.61M | $12.46M | -$45.71M |
| Cash & equivalents | $72.93M | n/a | $230.52M | $53.83M |
| Total assets | $399.48M | $817.15M | $726.16M | $225.87M |
| Total liabilities | $347.39M | $509.73M | $362.11M | $248.97M |
| Shareholders' equity | $52.45M | $307.42M | $364.05M | -$23.11M |
| Return on year-end equity | -9.8% | -22.2% | -28.4% | n/a |
| Shares outstanding | 37.23M | n/a | n/a | 65.01M |
Revenue, most recent five fiscal years
| Fiscal year | Harrow, Inc. | Vireo Growth Inc. | Schrodinger, Inc. | Evolus, Inc. |
|---|---|---|---|---|
| Latest | $272.30M Ended 2025-12-31 | $268.77M Ended 2025-12-31 | $255.87M Ended 2025-12-31 | $297.18M Ended 2025-12-31 |
| 1 year earlier | $199.61M Ended 2024-12-31 | $99.38M Ended 2024-12-31 | $207.54M Ended 2024-12-31 | $266.27M Ended 2024-12-31 |
| 2 years earlier | $130.19M Ended 2023-12-31 | $88.13M Ended 2023-12-31 | $216.67M Ended 2023-12-31 | $202.09M Ended 2023-12-31 |
| 3 years earlier | $88.59M Ended 2022-12-31 | $74.63M Ended 2022-12-31 | $180.96M Ended 2022-12-31 | $148.62M Ended 2022-12-31 |
| 4 years earlier | $72.48M Ended 2021-12-31 | $54.45M Ended 2021-12-31 | $137.93M Ended 2021-12-31 | $99.67M Ended 2021-12-31 |